Dopamine

Dopamine

SCHEMBL40952

Cl.NCCc1ccc(O)c(O)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRB1

The experimentally established mechanism targets of Dopamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 1.00
MAPT P10636 4/20 1.00
LMNA P02545 4/20 1.00
MAPK1 P28482 3/20 1.00
TDP1 Q9NUW8 3/20 1.00
BLM P54132 3/20 1.00
ADRA2A P08913 2/20 1.00
DRD2 P14416 2/20 1.00
DRD1 P21728 2/20 1.00
DRD4 P21917 2/20 1.00
DRD5 P21918 2/20 1.00
SLC6A2 P23975 2/20 1.00
DRD3 P35462 2/20 1.00
RECQL P46063 2/20 1.00
SLC6A3 Q01959 2/20 1.00
GAA P10253 2/20 1.00
GFER P55789 2/20 1.00
PMP22 Q01453 2/20 1.00
TAAR1 Q96RJ0 3/20 0.95
ALDH1A1 P00352 3/20 0.95

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dopamine SCHEMBL40951 1.00 KDM4E (1.00) KDM4EMAPTLMNAMAPK1TDP1
Dopamine SCHEMBL28324791 1.00 KDM4E (1.00) KDM4EMAPTLMNAMAPK1TDP1
Dopamine SCHEMBL29636832 1.00 KDM4E (1.00) KDM4EMAPTLMNAMAPK1TDP1
Dopamine SCHEMBL27754471 1.00 KDM4E (1.00) KDM4EMAPTLMNAMAPK1TDP1
Dopamine SCHEMBL3954271 1.00 KDM4E (1.00) KDM4EMAPTLMNAMAPK1TDP1
Dopamine SCHEMBL28285902 1.00 KDM4E (1.00) KDM4EMAPTLMNAMAPK1TDP1
Dopamine SCHEMBL23704750 1.00 KDM4E (1.00) KDM4EMAPTLMNAMAPK1TDP1
Dopamine SCHEMBL29831984 1.00 KDM4E (1.00) KDM4EMAPTLMNAMAPK1TDP1
Dopamine SCHEMBL30379446 1.00 KDM4E (1.00) KDM4EMAPTLMNAMAPK1TDP1
Dopamine SCHEMBL29201795 0.98 KDM4E (0.96) KDM4EMAPTLMNAMAPK1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 30833 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260146183-A1 SUPRAMOLECULAR HYDROGEL FILM FOR REVERSIBLE ADHESION OF FROZEN FOOD, PRODUCTION METHOD, AND APPLICATION NANJING AGRICULTURAL UNIVERSITY (CN) 2026-05-28 US claimed
US-20260145158-A1 APPLICATION OF CARBOXYLATED COVALENT ORGANIC MAGNETIC FRAMEWORK MATERIAL AS MAGNETIC SOLID-PHASE EXTRACTION ADSORBENT SOUTH CHINA UNIVERSITY OF TECHNOLOGY (CN) 2026-05-28 US claimed
CN-122075723-A Application of Lamp2b-IMTP fusion exosome in treating coronary heart disease 2026-05-26 CN claimed
CN-122091807-A Metal organic framework coated lithium supplementing agent and preparation method and application thereof 2026-05-26 CN claimed
CN-120464197-B Polyimide film and preparation method and application thereof Jiaxing Nanbo Precision Manufacturing Co.,Ltd. (CN) 2026-05-26 CN claimed
CN-117643648-B Injectable self-healing hydrogel dressing and preparation method and application thereof SICHUAN UNIVERSITY (CN) 2026-05-26 CN claimed
CN-122080727-A 8B cold-rolled precise steel strip and manufacturing method thereof 2026-05-26 CN claimed
CN-120324686-B GTR film and preparation method and application thereof SICHUAN UNIVERSITY (CN) 2026-05-26 CN claimed
CN-122076677-A Antibacterial composite coating based on quaternized nano zinc oxide and preparation method and application thereof 2026-05-26 CN claimed
CN-122080742-A Ultralow-VOC (volatile organic compound) graphene anti-corrosion curing coating and preparation method thereof 2026-05-26 CN claimed
WO-2001037808-A1 SOLID CARRIERS FOR IMPROVED DELIVERY OF ACTIVE INGREDIENTS IN PHARMACEUTICAL COMPOSITIONS LIPOCINE, INC. (US) 2001-05-31 WO claimed
WO-2001028555-A1 EMULSION COMPOSITIONS FOR POLYFUNCTIONAL ACTIVE INGREDIENTS LIPOCINE, INC. (US) 2001-04-26 WO claimed
WO-2001012155-A1 COMPOSITIONS AND METHODS FOR ENHANCED ABSORPTION OF HYDROPHILIC THERAPEUTIC AGENTS LIPOCINE, INC. (US) 2001-02-22 WO claimed
WO-2000021504-A1 ENCAPSULATION OF SENSITIVE LIQUID COMPONENTS INTO A MATRIX TO OBTAIN DISCRETE SHELF-STABLE PARTICLES GENERAL MILLS, INC. (US) 2000-04-20 WO claimed
EP-0935523-A4 EMBEDDING AND ENCAPSULATION OF CONTROLLED RELEASE PARTICLES GEN MILLS INC (US) 1999-12-29 EP claimed
EP-0935523-A1 EMBEDDING AND ENCAPSULATION OF CONTROLLED RELEASE PARTICLES GENERAL MILLS, INC. (US) 1999-08-18 EP claimed
US-5811547-A Method for inducing crystalline state transition in medicinal substance NIPPON SHINYAJU CO., LTD. (JP) 1998-09-22 US claimed
WO-1998018610-A1 EMBEDDING AND ENCAPSULATION OF CONTROLLED RELEASE PARTICLES LENGERICH BERNHARD H VAN (US) 1998-05-07 WO claimed
US-5288503-A WATER-PERMEABLE DIFFUSION BARRIER OF POLYVINYL ALCOHOL SRCHEM INCORPORATED (US) 1994-02-22 US claimed
US-5260066-A Cryogel bandage containing therapeutic agent SRCHEM INCORPORATED (US) 1993-11-09 US claimed